Severe vincristine neuropathy in Charcot-Marie-Tooth Disease Type 1A

Cancer

Volumn 77, Issue 7, 1996, Pages 1356-1362

  Graf, William D ^a,b,e   Chance, Phillip F ^c,d   Lensch, M William ^c,d   Eng, Lilly J ^a,b   Lipe, Hillary P ^a,b   Bird, Thomas D ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

17p11.2 12 duplication; Charcot Marie Tooth disease; hereditary motor and sensor neuropathy; neuropathy; neurotoxicity; vincristine

Indexed keywords

VINCRISTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE DUPLICATION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHATIC LEUKEMIA; LYMPHOMA; MALE; NEUROPATHY; NEUROTOXICITY; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

EID: 0030012140     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19960401)77:7<1356::aid-cncr20>3.3.co;2-s     Document Type: Article

References (31)

1. Bird TD. Hereditary motor-sensory neuropathies. Charcot-Marie-Tooth syndrome. Neurol Clin 1989; 7:9-23.
2. Dyck PJ, Chance PF, Lebo RV, Carney JA. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy, 3rd edition. Philadelphia: WB Saunders Co., 1993; 1094-136.
3. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth disease. Clin Genet 1974; 6:98-118.
4. Chance PF, Bird TD, O'Connell P, Lipe H, Lalouel J-M, Leppert M. Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I). Am J Hum Genet 1990; 47:915-25.
5. Chance PF, Matsunami N, Lensch W, Smith B, Bird TD. Analysis of the DNA duplication 17p11.2 in Charcot-Marie-Tooth neuropathy type 1 pedigrees. Neurology 1992; 42: 2037-41.
6. Lupski JR, de Oca Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66:219-32.
7. Raeymaekers P, Timmerman V, Nelis E, DeJonghe P, Hoogendijk JE, Baas F, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscular Disorders 1991; 1:93-7.
8. Weiden PL, Wright SE. Vincristine neurotoxicity. N Engl J Med 1972; 286:1369.
9. Gutmann L, Fakadej A, Riggs JE. Evolution of nerve conduction abnormalities in children with dominant hypertrophic neuropathy of the Charcot-Marie-Tooth type. Muscle Nerve 1983; 6:515-9.
10. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nature Genet 1992; 1:176-9.
11. Lupski JR, Wise CA, Kuwano A, Pentao L, Parke JT, Glaze DG, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nature Genet 1992; 1:29-33.
12. Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel P, et al. Molecular analyses of unrelated Charcot-Marie-Tooth disease patients suggest a high frequency of the CMT1A duplication. Am J Hum Genet 1993; 53:853-63.
13. Nicholson GA. Penetrance of the hereditary motor and sensory neuropathy Ia mutation: Assessment by nerve conduction studies. Neurology 1991; 41:547-52.
14. Hogan-Dann CM, Fellmeth WG, McGuire SA, Diley VA. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome. JAMA 1984; 252:2862-3.
15. Geny C, Gaio JM, Mallaret M, Goy A, Reymond F, Pegourie B, et al. Charcot-Marie-Tooth disease disclosed by a treatment with vincristine in familial Hodgkin disease (letter). Ann Med Intern 1990; 141:709-10.
16. Dicker Hoff R, Lindner W, Scheibler W. Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease (letter). Pediatr Hematol Oncol 1988; 5:61-4.
17. Griffiths JD, Stark RJ, Ding JC, Cooper IA. Vincristine neurotoxicity in Charcot-Marie-Tooth syndrome. Med J Aust 1985; 143:305-6.
18. Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci 1970; 10:107-31.
19. Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve 1987; 10: 80-4.
20. Gottschalk PG, Dyck PJ, Kiely JM. Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man. Neurology 1968; 18:875-82.
21. Kaplan RS, Wiernik PH. Neurotoxicity of antineoplastic drugs. Semin Oncol 1982; 9:103-30.
22. Timmerman V, Raeymaekers P, DeJonghe P, DeWinter G, Swerts L, Jacobs K, et al. Assignment of the Charcot-Marie-Tooth neuropathy type 1 (CMT 1A) gene to 17p11.2-p12. Am J Hum Genet 1990; 47:680-5.
23. Chance PF, Bird TD, Matsunami N, Lensch MW, Brothman AR, Feldman GM. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy type 1A phenotype. Neurology 1992; 42:2295-9.
24. Roa BB, Garcia CA, Suter U, Kulpa D, Wise C, Mueller J, et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993; 329:96-101
25. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nature Genet 1992; 1:159-65.
26. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, et al. The peripheral myelin protein-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nature Genet 1992; 1:176-9.
27. Valentijn LJ, Bolhuis PA, Zorn I, Hoogendijk JE, van den Bosch N, Hensels GW, et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nature Genet 1992; 1:166-70.
28. 0 gene. Nature Genet 1993; 5:31-4.
29. Bergoffen J, Scherer SS, Wang S, Oronzi Scott M, Bone LJ, Paul DL, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993; 2039-42.
30. Igarashi M, Thompson EI, Rivera GK. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy). Med Pediatr Oncol 1995; 25:113-6.
31. Weiss HD, Walker MD, Wiernik PH. Neurotoxicity of commonly used antineoplastic agents. N Engl J Med 1974; 291:75-81.